Conduent Uses GenAI to Transform Detection of Reportable Events
Conduent Incorporated (Nasdaq: CNDT), a global technology-driven business solutions and services firm, has introduced a new GenAI-powered solution designed to automate the detection of reportable events. This innovation establishes a new benchmark for FDA compliance.
Advancing Compliance for Pharma and Life Sciences
Powered by Microsoft Azure OpenAI, the solution supports Pharma and Life Sciences companies by automating reportable event detection across all customer channels.
Contact Information
- Media: Sean Collins, Conduent, +1-310-497-9205, [email protected]
- Investor Relations: Joshua Overholt, Conduent, [email protected]
"Conduent Applies GenAI to Revolutionize Detection of Reportable Events and Sets New Standard for FDA Compliance"
Author's summary: Conduent leverages Microsoft Azure OpenAI to introduce an AI-powered solution revolutionizing reportable event detection and enhancing FDA compliance for Pharma and Life Sciences.